Correlation Between X4 Pharmaceuticals and Artiva Biotherapeutics,
Can any of the company-specific risk be diversified away by investing in both X4 Pharmaceuticals and Artiva Biotherapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining X4 Pharmaceuticals and Artiva Biotherapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between X4 Pharmaceuticals and Artiva Biotherapeutics, Common, you can compare the effects of market volatilities on X4 Pharmaceuticals and Artiva Biotherapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in X4 Pharmaceuticals with a short position of Artiva Biotherapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of X4 Pharmaceuticals and Artiva Biotherapeutics,.
Diversification Opportunities for X4 Pharmaceuticals and Artiva Biotherapeutics,
0.28 | Correlation Coefficient |
Modest diversification
The 3 months correlation between XFOR and Artiva is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding X4 Pharmaceuticals and Artiva Biotherapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Artiva Biotherapeutics, and X4 Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on X4 Pharmaceuticals are associated (or correlated) with Artiva Biotherapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Artiva Biotherapeutics, has no effect on the direction of X4 Pharmaceuticals i.e., X4 Pharmaceuticals and Artiva Biotherapeutics, go up and down completely randomly.
Pair Corralation between X4 Pharmaceuticals and Artiva Biotherapeutics,
Given the investment horizon of 90 days X4 Pharmaceuticals is expected to generate 1.34 times more return on investment than Artiva Biotherapeutics,. However, X4 Pharmaceuticals is 1.34 times more volatile than Artiva Biotherapeutics, Common. It trades about 0.02 of its potential returns per unit of risk. Artiva Biotherapeutics, Common is currently generating about 0.02 per unit of risk. If you would invest 99.00 in X4 Pharmaceuticals on September 26, 2024 and sell it today you would lose (41.00) from holding X4 Pharmaceuticals or give up 41.41% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 36.01% |
| Values | Daily Returns |
X4 Pharmaceuticals vs. Artiva Biotherapeutics, Common
Performance |
| Timeline |
| X4 Pharmaceuticals |
| Artiva Biotherapeutics, |
X4 Pharmaceuticals and Artiva Biotherapeutics, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with X4 Pharmaceuticals and Artiva Biotherapeutics,
The main advantage of trading using opposite X4 Pharmaceuticals and Artiva Biotherapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if X4 Pharmaceuticals position performs unexpectedly, Artiva Biotherapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Artiva Biotherapeutics, will offset losses from the drop in Artiva Biotherapeutics,'s long position.| X4 Pharmaceuticals vs. Fate Therapeutics | X4 Pharmaceuticals vs. Caribou Biosciences | X4 Pharmaceuticals vs. Karyopharm Therapeutics | X4 Pharmaceuticals vs. Hookipa Pharma |
| Artiva Biotherapeutics, vs. Fate Therapeutics | Artiva Biotherapeutics, vs. Caribou Biosciences | Artiva Biotherapeutics, vs. Karyopharm Therapeutics | Artiva Biotherapeutics, vs. Hookipa Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Other Complementary Tools
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |